Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Helen Tager-Flusberg, director of the Center for Autism Research Excellence at Boston University, called Trump’s comments dangerous. Fevers can harm the mother and the developing fetus, she said, ...

HealthDay News — Louisiana health officials have confirmed a fifth death this year linked to Vibrio vulnificus, a rare and dangerous flesh-eating bacteria found in warm coastal waters.

Vaccination against measles, mumps, rubella, and varicella is typically administered in 2 doses: the first between 12 to 15 months and the second at 4 to 6 years.

The ACHIEVE-3 trial was a 52-week, randomized, open-label study that included 1698 T2D patients inadequately controlled on metformin.

Women with acute stroke are less likely than men to be accurately identified as having a stroke in the prehospital setting, ...

HealthDay News — Hormone replacement therapy (HRT) patches carry lower cardiovascular risk than oral HRT among women with type 2 diabetes, according to a study presented at the annual meeting of the ...

HealthDay News — A deep learning model based on mammographic features and age predicts cardiovascular risk with performance comparable to traditional risk equations, according to a study published ...

HealthDay News — Cannabis use is associated with a nearly quadrupled risk for developing type 2 diabetes, according to a study presented at the annual meeting of the European Association for the Study ...

The researchers found a significant 14% reduction in skin cancer risk overall after nicotinamide exposure. HealthDay News — For patients treated with nicotinamide, the risk for skin cancer is reduced, ...